Illumina (ILMN) Expected to Beat Earnings Estimates: Can the Stock Move Higher?Zacks Investment Research • 10/27/22
Illumina and GenoScreen Partner to Expand Access to Genomic Testing for Multidrug-Resistant TuberculosisPRNewsWire • 10/18/22
Illumina to Host Second Annual Virtual ESG Investor Event on Friday, October 28, 2022PRNewsWire • 10/17/22
GRAIL and Carrum Health Partner to Include Galleri® as Part of Comprehensive Cancer Care Offering to EmployersBusiness Wire • 10/13/22
Illumina Launches Strategic Research Collaboration with AstraZeneca to Accelerate Drug Target DiscoveryPRNewsWire • 10/11/22
Illumina to Announce Third Quarter 2022 Financial Results on Thursday, November 3, 2022PRNewsWire • 10/06/22
Illumina Introduces Multiple Breakthrough Sequencing Innovations at Inaugural Genomics ForumPRNewsWire • 09/29/22
Illumina Unveils Revolutionary NovaSeq X Series to Rapidly Accelerate Genomic Discoveries and Improve Human HealthPRNewsWire • 09/29/22
Illumina Genomics Forum Sold Out, Announces Opportunity to View Innovation Roadmap Session via LivestreamPRNewsWire • 09/26/22
John Hancock becomes the first life insurance carrier to offer access to GRAIL's multi-cancer early detection test to customersPRNewsWire • 09/20/22
Illumina Genomics Forum to Feature Nobel Laureate Frances Arnold as part of Distinguished Panel on How the Genomics Revolution Is Transforming Patient CarePRNewsWire • 09/19/22
Illumina Genomics Forum to Convene Leading Visionaries to Explore Architecting Health's Radically New InfrastructurePRNewsWire • 09/12/22
CORRECTING and REPLACING GRAIL Announces Final Results From the PATHFINDER Multi-Cancer Early Detection Screening Study at ESMO Congress 2022Business Wire • 09/11/22